LeadIQ logo
Learn more at LeadIQ.com

Insights

Adoptive Cell Therapies Pipeline Immatics Biotechnologies GmbH is actively developing Adoptive Cell Therapies (ACT) and TCR bispecifics, presenting an opportunity for collaboration and partnerships in the field of cancer immunotherapy.

Financial Growth Receiving significant financing, including a $175 million public offering and investments from Walleye Capital, indicates financial stability and potential for further investments or business expansion.

Partnership with Moderna The strategic partnership with Moderna for developing novel therapies targeting cancer indications opens doors for potential joint ventures or collaborations leveraging mRNA technology.

Expansion in mRNA Therapeutics Teaming up with CytomX, Personalis, and Moderna to develop mRNA-based therapeutics showcases a strong focus on innovative treatments, offering opportunities for partnerships with industry leaders.

Leadership Addition The recent appointment of Alise Reicin to the Board of Directors brings new expertise to the company, creating opportunities for networking and expanding business horizons.

Immatics Tech Stack

Immatics uses 8 technology products and services including SAP, NetApp, Veeva Vault, and more. Explore Immatics's tech stack below.

  • SAP
    Customer Relationship Management
  • NetApp
    Data Management
  • Veeva Vault
    Enterprise Content Management
  • Dell
    IT Infrastructure
  • RSS
    Miscellaneous
  • Microsoft Azure
    Platform As A Service
  • Perl
    Programming Languages
  • Python
    Programming Languages

Media & News

Immatics's Email Address Formats

Immatics uses at least 1 format(s):
Immatics Email FormatsExamplePercentage
First.Last@immatics.comJohn.Doe@immatics.com
61%
Last@immatics.comDoe@immatics.com
33%
First.Last@immatics.comJohn.Doe@immatics.com
3%
First@immatics.comJohn@immatics.com
3%

Frequently Asked Questions

Where is Immatics's headquarters located?

Minus sign iconPlus sign iconImmatics's main headquarters is located at Paul-Ehrlich-Str. 15 Tuebingen, 72076 DE. The company has employees across 4 continents, including EuropeNorth AmericaAfrica.

What is Immatics's phone number?

Minus sign iconPlus sign icon You can contact Immatics's main corporate office by phone at +1-346-204-5400. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Immatics's stock symbol?

Minus sign iconPlus sign iconImmatics is a publicly traded company; the company's stock symbol is IMTX.

What is Immatics's official website and social media links?

Minus sign iconPlus sign iconImmatics's official website is immatics.com and has social profiles on LinkedIn.

How much revenue does Immatics generate?

Minus sign iconPlus sign icon As of August 2024, Immatics's annual revenue reached $75M.

What is Immatics's SIC code NAICS code?

Minus sign iconPlus sign iconImmatics's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Immatics have currently?

Minus sign iconPlus sign iconAs of August 2024, Immatics has approximately 501 employees across 4 continents, including EuropeNorth AmericaAfrica. Key team members include Chief Medical Officer: C. M. B.Chief Financial Officer: D. M.Chief Financial Officer: A. C.. Explore Immatics's employee directory with LeadIQ.

What industry does Immatics belong to?

Minus sign iconPlus sign iconImmatics operates in the Biotechnology Research industry.

What technology does Immatics use?

Minus sign iconPlus sign iconImmatics's tech stack includes SAPNetAppVeeva VaultDellRSSMicrosoft AzurePerlPython.

What is Immatics's email format?

Minus sign iconPlus sign iconImmatics's email format typically follows the pattern of . Find more Immatics email formats with LeadIQ.

When was Immatics founded?

Minus sign iconPlus sign iconImmatics was founded in 2000.
Immatics

Immatics

Biotechnology ResearchTuebingen, Germany501-1000 Employees

Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer.

Read more about Immatics on our homepage: https://immatics.com/

Find us also on:
Twitter: https://twitter.com/immatics
Instagram: https://www.instagram.com/immatics/
YouTube: https://www.youtube.com/channel/UCv7uTpsGXvSNzwSX_xOtYSA

Legal notice: https://immatics.com/imprint/

Section iconCompany Overview

Headquarters
Paul-Ehrlich-Str. 15 Tuebingen, 72076 DE
Phone number
+1-346-204-5400
Website
immatics.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
IMTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2000
Employees
501-1000

Section iconMedia & News

Section iconFunding & Financials

  • $50M$100M

    Immatics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Immatics's revenue is in the range of $50M$100M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.